KMT2A and acute myeloid leukemia: An unanticipated powerful way for lowering Myc levels in haematopoietic cancers has emerged from the discovery that the incurable nature of MLL-AF9 acute myeloid leukaemia (AML) depends upon the presence of the not yet well understood protein bromodomain 4 (BRD4).